Abacavir Sulfate; Lamivudine Patent Expiration
Abacavir Sulfate; Lamivudine is Used for treating HIV infection. It was first introduced by Viiv Healthcare Co
Abacavir Sulfate; Lamivudine Patents
Given below is the list of patents protecting Abacavir Sulfate; Lamivudine, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Epzicom |
US6294540 (Pediatric) | Carbocyclic nucleoside hemisulfate and its use in treating viral infections |
Nov 14, 2018
(Expired) | Viiv Hlthcare |
Epzicom | US6294540 | Carbocyclic nucleoside hemisulfate and its use in treating viral infections |
May 14, 2018
(Expired) | Viiv Hlthcare |
Epzicom |
US5905082 (Pediatric) | Crystalline oxathiolane derivatives |
Nov 18, 2016
(Expired) | Viiv Hlthcare |
Epzicom |
US6417191 (Pediatric) | Synergistic combinations of zidovudine, 1592U89 and 3TC |
Sep 28, 2016
(Expired) | Viiv Hlthcare |
Epzicom | US5905082 | Crystalline oxathiolane derivatives |
May 18, 2016
(Expired) | Viiv Hlthcare |
Epzicom | US6417191 | Synergistic combinations of zidovudine, 1592U89 and 3TC |
Mar 28, 2016
(Expired) | Viiv Hlthcare |
Abacavir Sulfate; Lamivudine's Family Patents
Explore Our Curated Drug Screens
Abacavir Sulfate; Lamivudine Generic API Manufacturers
Several generic applications have been filed for Abacavir Sulfate; Lamivudine. The first generic version for Abacavir Sulfate; Lamivudine was by Teva Pharmaceuticals Usa and was approved on Sep 29, 2016. And the latest generic version is by Laurus Labs Ltd and was approved on Jul 25, 2022.
Given below is the list of companies who have filed for Abacavir Sulfate; Lamivudine generic, along with the locations of their manufacturing plants worldwide.
1. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 1 generic for Abacavir Sulfate; Lamivudine. This eq 600mg base;300mg version comes by the name ABACAVIR SULFATE AND LAMIVUDINE. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 600MG BASE; 300MG | tablet | Discontinued | ORAL | N/A | Mar 28, 2017 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
India |
| |||||||||
United States |
|
2. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 1 generic for Abacavir Sulfate; Lamivudine. This eq 600mg base;300mg version comes by the name ABACAVIR SULFATE AND LAMIVUDINE. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 600MG BASE; 300MG | tablet | Prescription | ORAL | AB | Nov 15, 2018 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
India |
|
3. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Abacavir Sulfate; Lamivudine. This eq 600mg base;300mg version comes by the name ABACAVIR SULFATE AND LAMIVUDINE. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 600MG BASE; 300MG | tablet | Prescription | ORAL | AB | Mar 28, 2017 |
4. CIPLA
Cipla Ltd has filed for 1 generic for Abacavir Sulfate; Lamivudine. This eq 600mg base;300mg version comes by the name ABACAVIR SULFATE AND LAMIVUDINE. Given below are the details of the strengths of this generic introduced by Cipla.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 600MG BASE; 300MG
(reference standard) | tablet | Prescription | ORAL | AB | Mar 28, 2017 |
Manufacturing Plant Locations New
Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.
Country | City | Firm Name | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
|
5. LAURUS
Laurus Labs Ltd has filed for 1 generic for Abacavir Sulfate; Lamivudine. This eq 600mg base;300mg version comes by the name ABACAVIR SULFATE AND LAMIVUDINE. Given below are the details of the strengths of this generic introduced by Laurus.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 600MG BASE; 300MG | tablet | Prescription | ORAL | AB | Jul 25, 2022 |
Manufacturing Plant Locations New
Laurus's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Laurus as present at those locations.
Country | City | Firm Name | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
|
6. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 1 generic for Abacavir Sulfate; Lamivudine. This eq 600mg base;300mg version comes by the name ABACAVIR SULFATE AND LAMIVUDINE. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 600MG BASE; 300MG | tablet | Discontinued | ORAL | N/A | Sep 29, 2016 |
7. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Abacavir Sulfate; Lamivudine. This eq 600mg base;300mg version comes by the name ABACAVIR SULFATE AND LAMIVUDINE. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 600MG BASE; 300MG | tablet | Discontinued | ORAL | N/A | Nov 15, 2018 |